P

Prothena Corp
D

PRTA

15.540
USD
0.27
(1.77%)
مغلق
حجم التداول
32,362
الربح لكل سهم
-3
العائد الربحي
-
P/E
-6
حجم السوق
836,187,695
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ALNY
    ALNY
    -0.480
    (-0.19%)
    250.450 USD
    B
    BLUE
    -2.93000
    (-41.68%)
    4.10000 USD
    BMY
    BMY
    0.050
    (0.09%)
    55.840 USD
    GILD
    GILD
    -0.140
    (-0.13%)
    109.920 USD
    I
    IMUX
    0.09000
    (7.63%)
    1.27000 USD
    I
    INCY
    0.790
    (1.11%)
    72.150 USD
    MRNA
    MRNA
    1.785
    (5.29%)
    35.535 USD
    REGN
    REGN
    4.37
    (0.63%)
    700.66 USD
    VRTX
    VRTX
    4.10
    (0.85%)
    484.53 USD
    المزيد
الأخبار
المقالات

العنوان: Prothena Corp

القطاع: Healthcare
الصناعة: Biotechnology
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).